A recently approved injectable eczema drug, Nemluvio, provides quick itch relief to patients with the maddening skin disease, ...

Exposure to antibiotics during immune checkpoint inhibitor therapy may increase the risk for immune-related cutaneous adverse ...

The most common concern of chemotherapy patients is that their skin is not the same as before", "A handful of hair is falling out."It's hard to walk because my nails hurt" It's a story of the same ...

Scientists have uncovered how too much sunlight can flip a hidden switch inside skin cells that makes inflammation spiral out of control and increases the risk of cancer. Their research reveals that ...

A massive Veterans Affairs study has confirmed that nicotinamide may offer real protection against skin cancer. Patients who took the vitamin B3 derivative saw notable reductions in new cancer ...

If you or someone you love has ever dealt with frequent dry, red or itchy patches of skin, you likely know how frustrating eczema can be. The condition can impact confidence, comfort and daily routine ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

A common vitamin could help prevent the development of skin cancer, new research suggests. The study, published in JAMA Dermatology, found a decreased risk of three types of skin cancer associated ...

A form of B3 called nicotinamide cut the risk of developing repeat skin cancers by as much as 54 percent, according to new research. A large new study found that nicotinamide, a form of vitamin B3, ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. A new study found nicotinamide supplements may cut the ...

Nicotinamide significantly reduces new skin cancer risk, especially when started early, with a 54% reduction after a first diagnosis. The study's findings align with previous trials, reinforcing ...